Epidemiology of Pulmonary Tuberculosis

Editorial

Austin Tuberc Res Treat. 2017; 2(1): 1005.

Epidemiology of Pulmonary Tuberculosis

Shahverdi E1,2 and Khani MA3*

¹Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Iran

²Mahak Pediatric Cancer Treatment and Research Center, Iran

³Department of Medicine, Najafabad Branch, Islamic Azad University, Najafabad, Iran

*Corresponding author: Maryam Allahverdi Khani, Islamic Azad University of Medical Sciences, Pouryaye Vali Blvd, Najafabad, Isfahan, Iran

Received: March 01, 2017; Accepted: March 20, 2017; Published: March 29, 2017

Editorial

Analysis of trends in disease is one of the methods of epidemiological analysis which is used for monitoring, controlling and forecasting programs, policy analysis and etiology of diseases.

Since doctors will be able to be combined clinical and epidemiological approach to eradicate a disease completely and clinical treatment alone is an insufficient measure to deal with the problem of tuberculosis, it is considered as the essential introduction to epidemiology. Tuberculosis (TB) is an infectious disease and generally is caused by Mycobacterium tuberculosis [1]. Tuberculosis is one of the oldest diseases which affect humans. Now among microbial diseases, tuberculosis is the most common fatal disease for adults worldwide. Almost a third of the world’s population is infected with TB germs and are in the risk of tuberculosis. Every year about 9 million people develop active TB and 1.5-2 million people die from the disease [2].

The incidence of tuberculosis in different parts of the world is different; Africa, with about 365 cases per hundred thousand people has the highest prevalence rate [3]. More than 90% of TB cases and deaths occur in developing countries in which 75% of the cases belong to the economically most active age group i.e. 15 to 54 years old. This disease is the largest cause of death from single factor of infectious disease and ranks tenth in the global burden of diseases and is expected to continue to maintain its current position until 2020 and even climb to seventh place [4].

Although the most common site of infection is tuberculosis of the lungs, but can affect any part of the body [1,5]. Pulmonary tuberculosis is one of the most important infectious diseases in humans and despite the use of anti-TB drugs that is one of the major causes of mortality, particularly in developing countries, and today is one of the major global health problems [6]. Pulmonary tuberculosis make up more than 80 percent of TB cases and, in adults with sputum smear-positive mainly, is highly contagious in this case [7].

Epidemiologists believe that in 1.2% of cases tuberculous infection leads to cavity pulmonary tuberculosis that this mode is highly contagious pulmonary tuberculosis so that each patient has a cavity on average 20 another person’s infection [8]. TB detection methods are different according to the type of TB. In pulmonary tuberculosis, methods of direct smear sputum and sputum culture are used as the main methods to detect disease and in non-pulmonary tuberculosis depending on the member caught using bacteriological tests, radiological, histological and another complementary approach is diagnosed by the doctor. If pulmonary tuberculosis patients are not timely diagnosed and treated, it would cause the drug-resistant tuberculosis [9]. After the advent of HIV, AIDS was introduced as the most important risk of conversion asymptomatic infection to tuberculosis [10]. Accompaniment tuberculosis and HIV causes a devastating crisis public health crisis on a global level as almost a third of global deaths from AIDS is tuberculosis, and infection of HIV, increases the risk of TB infection about 100 times. The risk of tuberculosis infects a person with untreated HIV with positive PPD test in about 7 to 10 percent per year [9].

There are several reasons to suggest that smoking makes a person susceptible to tuberculosis. For example, has changed immune response and is defective macrophage-monocyte immune response and reduce the number of CD4 lymphocytes [11]. Smoking reduces the intrinsic and acquired resistance of human to Mycobacterium tuberculosis. Exposure to tobacco smoke alters the function and morphology of alveolar macrophages [12]. Children exposure to cigarette smoke increases the chances of early transformation of TB infection to pulmonary tuberculosis [11]. Considering the relationship between smoking and tuberculin in some studies, it was stated that positive tuberculin has greater chance in smokers [13].

From 8.9 million new cases worldwide, 3.9 million were associated with patients with smear-positive pulmonary tuberculosis in 2004 [14].

The incidence of TB is not the same in various locations. The World Health Organization has identified targets for TB control that most important being that the incidence of TB by 2015 in the world to reach 50 percent of its level in 1990 and by 2050 the rate of death from active TB is reduced to one in a million. According to the TB control program, the emphasis on screening and treatment of patients with pulmonary tuberculosis and the success of the program requires an understanding of the infection or spreading pattern of the disease and its risk factors.

The extent of the outbreak and contagious requires extensive studies on the predisposing factors and diseases such as HIV, diabetes mellitus, drug, and malnutrition as well as discussing drug-resistant TB and the risk in elderly. Screening, to identify more quickly is important for patients to appropriate treatment and reduces transmission to others.

To reach tuberculosis control targets need to be included in activities that lead to increased early detection and effective treatment of patients in countries with TB control strategies. To design a comprehensive program to control the disease, epidemiological studies are of great importance.

References

  1. Steingart KR, Henry M, Ng V, Hopewell PC, Ramsay A, Cunningham J, et al. Fluorescence versus conventional sputum smear microscopy for tuberculosis: a systematic review. The Lancet Infectious Diseases. 2006; 6: 570-581.
  2. Organization WH. Global tuberculosis control 2009: epidemiology, strategy, financing: World Health Organization; 2009.
  3. Organization WH. Global and regional incidence, Tuberculosis Fact sheet N 104. WHO; 2006.
  4. Organization WH. Treatment of tuberculosis: guidelines for national programmes: World Health Organization; 1993.
  5. Bennett JE, Dolin R, Blaser MJ. Mandell, Douglas, and Bennett’s principles and practice of infectious diseases: Elsevier Health Sciences. 2014.
  6. Stewart GR, Newton SM, Wilkinson KA, Humphreys IR, Murphy HN, Robertson BD, et al. The stress-responsive chaperone a-crystallin 2 is required for pathogenesis of Mycobacterium tuberculosis. Molecular Microbiology. 2005; 55: 1127-1137.
  7. Hale T, Held D. Handbook of transnational governance: Polity. 2011.
  8. Abubakar I, Averhoff A, Buff A. Tuberculosis and air travel-guidelines for prevention and control. 2008: 399.
  9. Azizi F, Hatami H, Janghorbani M. Epidemiology and control of common diseases in Iran. Tehran: Eshtiagh Publications. 2000: 602-616.
  10. Selwyn PA, Hartel D, Lewis VA, Schoenbaum EE, Vermund SH, Klein RS, et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. New England Journal of Medicine. 1989; 320: 545-550.
  11. Altet M, Alcaide J, Plans P, Taberner J, Salto E, Folguera L, et al. Passive smoking and risk of pulmonary tuberculosis in children immediately following infection. A case-control study. Tubercle and Lung Disease. 1996; 77: 537- 544.
  12. Hocking WG, Golde DW. The pulmonary-alveolar macrophage. New England Journal of Medicine. 1979; 301: 580-587.
  13. McCurdy SA, Arretz DS, Bates RO. Tuberculin reactivity among California Hispanic migrant farm workers. American Journal of Industrial Medicine. 1997; 32: 600-605.
  14. Dye C. Global epidemiology of tuberculosis. The Lancet. 2006; 367: 938-940.

Download PDF

Citation: Shahverdi E and Khani MA. Epidemiology of Pulmonary Tuberculosis. Austin Tuberc Res Treat. 2017; 2(1): 1005.

Home
Journal Scope
Online First
Current Issue
Editorial Board
Instruction for Authors
Submit Your Article
Contact Us